Metrikler
Yayın
103
Açık Erişim
13
BM Sürdürülebilir Kalkınma Amaçları
Araştırma Alanları
Tıp
Sağlık Bilimleri
Dahili Tıp Bilimleri
İç Hastalıkları
Onkoloji
Akademik Faaliyetlere Dayalı Araştırma Alanları
Avesis Araştırma Alanları
WoS Araştırma Alanları
Scopus Araştırma Alanları
Makaleler
Tümü (96)
SCI-E, SSCI, AHCI (85)
SCI-E, SSCI, AHCI, ESCI (90)
ESCI (5)
Scopus (92)
TRDizin (7)
2026
20261. Real-world Efficacy and Safety of Trastuzumab Deruxtecan in HER2-positive Metastatic Breast Cancer: A Multicenter Retrospective Study from Türkiye
Muğlu H., SÜNGER E., ŞEKER CAN L., Han Ö., Güney B., HAMDARD J., et al.
Journal of Oncological Science
, cilt.12, sa.1, ss.59-66, 2026 (Scopus, TRDizin)
2025
20252. Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors
Sucuoğlu İşleyen Z., MUĞLU H., Alaca Topçu Z., Beşiroğlu M., Yasin A. İ., Topçu A., et al.
Medicina (Lithuania)
, cilt.61, sa.7, 2025 (SCI-Expanded, Scopus)
2025
20253. Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience
HAMDARD J., BİLİCİ A., Sakin A., Kahraman S., YASİN A. İ., KALACI E., et al.
JOURNAL OF CHEMOTHERAPY
, cilt.37, sa.3, ss.268-277, 2025 (SCI-Expanded, Scopus)
2024
20244. Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram
Yasin A. I., ULUGANYAN M., Isleyen Z. S., Topcu A., Shbair A. T., ŞİMŞEK M., et al.
Supportive Care in Cancer
, cilt.32, sa.8, 2024 (SCI-Expanded, Scopus)
2024
20245. Is Clinical Risk Score a Useful Predictive Marker of Early Recurrence Among Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors?
OVEN B. B., ÖKTEN I. N., BİLİCİ A., YASİN A. I., KOCA S., YÜZÜGÜLLÜ E., et al.
Eurasian Journal of Medical Investigation
, cilt.8, sa.2, ss.106-112, 2024 (TRDizin)
2024
20246. Pretreatment HALP Score Predicts Prognosis in Patients with Esophageal Cancer Treated with Chemoradiotherapy
İŞLEYEN Z. S., BEŞİROĞLU M., ŞİMŞEK M., YASİN A. İ., TOPÇU A., AKÇAKAYA A., et al.
Eurasian Journal of Medical Investigation
, cilt.8, sa.2, ss.113-118, 2024 (TRDizin)
2024
20247. Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer
KUTLU Y., Cekin R., AYDIN S., Shbair A. T. M., BİLİCİ A., Arici S., et al.
Current Problems in Cancer
, cilt.50, 2024 (SCI-Expanded, Scopus)
2023
20238. Local interventions for colorectal cancer metastases to liver and lung
ŞİMŞEK M., Besiroglu M., AKÇAKAYA A., Topcu A., Yasin A. I., Isleyen Z. S., et al.
Irish Journal of Medical Science
, cilt.192, sa.6, ss.2635-2641, 2023 (SCI-Expanded, Scopus)
2023
20239. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study
AYDIN S., Kavak E. E., Topcu A., BAYRAMGİL A., Akgul F., Kahraman S., et al.
Biomolecules and Biomedicine
, cilt.23, sa.6, ss.1089-1095, 2023 (SCI-Expanded, Scopus)
2023
202310. The prognostic value of tumor budding in gastric adenocarcinomas: A cross-sectional study
Baydas T., ÇOBAN G., Besiroglu M., ŞİMŞEK M., Shbair A. T., Topcu A., et al.
International Journal of Gastrointestinal Intervention
, cilt.12, sa.2, ss.69-74, 2023 (ESCI, Scopus)
2022
202211. The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer
ŞİMŞEK M., Yasin A., BEŞİROĞLU M., TOPÇU A., SUCUOĞLU İŞLEYEN Z., ŞEKER M., et al.
JOURNAL OF MEDICAL VIROLOGY
, cilt.94, sa.9, ss.4138-4143, 2022 (SCI-Expanded, Scopus)
2022
202212. Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).
Bilici A., Olmez O. F., Sezer A., Oksuzoglu B., Kaplan M. A., Karadurmus N., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.40, sa.16, 2022 (SCI-Expanded, Scopus)
2022
202213. Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study
YASİN A. İ., Aydin S. G., SÜMBÜL B., KORAL L., ŞİMŞEK M., Geredeli C., et al.
FUTURE ONCOLOGY
, cilt.18, ss.1235-1244, 2022 (SCI-Expanded, Scopus)
2022
202214. The Impact of Hybrid Capture-Based Comprehensive Genomic Profiling on Treatment Strategies in Patients with Solid Tumors
Dişel U., Köse F., Bilici A., ÖZGÜROĞLU M., Sağlam S., ŞEKER M., et al.
Journal of Oncological Science
, cilt.8, sa.2, ss.87-93, 2022 (Scopus, TRDizin)
2022
202215. Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer
Goktas Aydin S., Cakan Demirel B., Bilici A., TOPÇU A., Aykan M. B., KAHRAMAN S., et al.
Current Medical Research and Opinion
, cilt.38, sa.10, ss.1751-1758, 2022 (SCI-Expanded, Scopus)
2022
202216. A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer
TOPÇU A., YASİN A. İ., SHBAIR A. T., BEŞİROĞLU M., ŞİMŞEK M., SUCUOĞLU İŞLEYEN Z., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.28, sa.1, ss.242-246, 2022 (SCI-Expanded, Scopus)
2021
202117. Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer
Acikgoz O., Cakan B., DEMİR T., Bilici A., Oven B. B., Hamdard J., et al.
MEDICINE
, cilt.100, sa.44, 2021 (SCI-Expanded, Scopus)
2021
202118. Primitive Neuroectodermal Tumor of the Testis
DEMİR T., ALİYEV A., ŞEKER M., ERSÖZ C., ÇOBAN G., TÜRK H. M.
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
, cilt.31, sa.11, ss.1362-1365, 2021 (SCI-Expanded, Scopus)
2021
202119. Evaluation of Kidney Function in Patients on Chemotherapy
Haziyev E., GÜRSU M., ŞEKER M., ELÇİOĞLU Ö. C., ARTAN A. S., ALİYEV A., et al.
TURKISH JOURNAL OF NEPHROLOGY
, cilt.30, sa.2, ss.138-144, 2021 (ESCI, Scopus, TRDizin)
2021
202120. Clinicopathological features of gastroenteropancreatic neuroendocrine neoplasms: a retrospective single-center experience
ŞEKERCİ A., TÜRK H. M., DEMİR T., ŞEKER M., AKÇAKAYA A., ARICI D. S.
NEUROENDOCRINOLOGY
, cilt.111, ss.20, 2021 (SCI-Expanded, Scopus)
2020
202021. Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study.
Disel U., Kose F., Bilici A., Ozguroglu M., Saglam S., Seker M., et al.
JOURNAL OF CLINICAL ONCOLOGY
, cilt.38, sa.15, 2020 (SCI-Expanded, Scopus)
2020
202022. Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.
Turk H. M., Aliyev A., Celik R., Seker M., Coban E., Demir T., et al.
Current problems in cancer
, cilt.44, sa.1, ss.100497, 2020 (SCI-Expanded, Scopus)
2020
202023. Correlationof Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy.
ŞEKER M., AYDIN D., BİLİCİ A., YAVUZER D., GEÇER M., ÖZÇELİK M., et al.
Oncology Research
, 2020 (SCI-Expanded, Scopus)
2019
201924. Prognostic Factors for Operated Gallbladder Cancer.
Oven U., Bilici A., Seker M., Kefeli U., Aydin D., Celik S., et al.
Journal of gastrointestinal cancer
, cilt.50, ss.451-457, 2019 (ESCI, Scopus)
2019
201925. Prognostic Impact of Primary Tumor Location on Survival in Metastatic Colorectal Cancer Patients: A single center experience
DEMİR T., ARAZ M., ÇOBAN E., ALİYEV A., ŞEKER M., TÜRK H. M.
Medicine Science
, cilt.8, sa.3, ss.500-502, 2019 (TRDizin)
2019
201926. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy.
Bilici A., Selcukbiricik F., Seker M., Oven B., Olmez O., Yildiz O., et al.
Oncology research and treatment
, cilt.42, ss.209-216, 2019 (SCI-Expanded, Scopus)
2018
201827. Cutaneous Involvement of Lung Adenocarcinom
Cengiz F. P., Tosuner Z., Sonmez B., Seker M., Emiroglu N., Turk H. M., et al.
BEZMIALEM SCIENCE
, cilt.6, sa.4, ss.329-330, 2018 (ESCI, TRDizin)
2018
201828. Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients
Seker M., ISEN H. C., Cevirme N., Aydin S., Bilici A., Bulut H., et al.
ONCOLOGY RESEARCH AND TREATMENT
, cilt.41, sa.9, ss.545-549, 2018 (SCI-Expanded, Scopus)
2017
201729. Scalp recurrence of cholangiocarcinoma after curative hepatectomy: A report of two cases
Kunduz E., Serin K. R., Şeker M.
MOLECULAR AND CLINICAL ONCOLOGY
, cilt.7, sa.6, ss.1122-1124, 2017 (ESCI, Scopus)
2017
201730. Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy
Seker M., AYDIN D., Bilici A., YAVUZER D., OZGUN M., OZCELIK M., et al.
ONCOLOGY RESEARCH AND TREATMENT
, sa.4, ss.185-190, 2017 (SCI-Expanded, Scopus)
2016
201631. Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients
OZCELIK M., KORKMAZ T., ODABAS H., GEMICI C., ERCELEP O., YUKSEL S., et al.
TUMOR BIOLOGY
, cilt.37, sa.7, ss.8901-8907, 2016 (SCI-Expanded, Scopus)
2016
201632. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology
OZCELIK M., ŞEKER M., ERASLAN E., Koca S., YAZILITAS D., ERCELEP O., et al.
Tumor Biology
, cilt.37, sa.4, ss.5231-5237, 2016 (SCI-Expanded, Scopus)
2016
201633. Pretreatment PET/ct standardized uptake values play a role in predicting response to treatment and survival in patients with small cell lung cancer
DINC N. S., AYDLN K., ODABAS H., ERCELEP O., Tufan G., ŞEKER M., et al.
Oncology Research and Treatment
, cilt.39, sa.3, ss.130-134, 2016 (SCI-Expanded, Scopus)
2015
201534. The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?
BILICI A., SONKAYA A., ERCAN S., USTAALIOĞLU B., Seker M., ALIUSTAOGLU M., et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
, cilt.36, ss.823-8, 2015 (SCI-Expanded, Scopus)
2014
201435. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.
BILICI A., INANC M., ULAS A., AKMAN T., Seker M., BABACAN N., et al.
Asian Pacific journal of cancer prevention : APJCP
, cilt.14, ss.6493-9, 2014 (SCI-Expanded, Scopus)
2014
201436. Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey
OVEN USTAALIOGLU B. B., Bilici A., YILMAZ B. E., ALIUSTAOGLU M., Seker M., VARDAR F., et al.
Breast Care
, cilt.9, sa.2, ss.123-127, 2014 (SCI-Expanded, Scopus)
2014
201437. Treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology
Mehmet K., SENER C., UYETURK U., Seker M., Tastekin D., Tonyali O., et al.
Wspolczesna Onkologia
, cilt.18, sa.4, ss.273-278, 2014 (SCI-Expanded, Scopus)
2013
201338. Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.
KEFELI U., BUYUBERBER S., AKYOL M., YILDIZ R., KAPLAN M., CILTAS A., et al.
Hepato-gastroenterology
, cilt.60, ss.647-52, 2013 (SCI-Expanded, Scopus)
2013
201339. The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.
USTAALIOĞLU B., BILICI A., ERCAN S., Seker M., ORCUN A., GUMUS M.
Medical oncology (Northwood, London, England)
, cilt.30, ss.551, 2013 (SCI-Expanded, Scopus)
2013
201340. Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey.
Seker M., SEVINC A., YILDIZ R., CIHAN S., KAPLAN M., GOKDURNALI A., et al.
Hepato-gastroenterology
, cilt.60, ss.768-75, 2013 (SCI-Expanded, Scopus)
2013
201341. Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology.
KAPLAN M., ISIKDOGAN A., GUMUS M., ARSLAN U., GEREDELI C., OZDEMIR N., et al.
Journal of pediatric hematology/oncology
, cilt.35, ss.83-9, 2013 (SCI-Expanded, Scopus)
2013
201342. XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.
UYGUN K., BILICI A., KAYA S., Oven U., YILDIZ R., TEMIZ S., et al.
Asian Pacific journal of cancer prevention : APJCP
, cilt.14, ss.2283-8, 2013 (SCI-Expanded, Scopus)
2012
201243. The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.
BILICI A., USTAALIOĞLU B., ERCAN S., Seker M., YILMAZ B., ORCUN A., et al.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
, cilt.33, ss.2201-8, 2012 (SCI-Expanded, Scopus)
2012
201244. Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.
ELKIRAN E., KAPLAN M., SEVINC A., AKSOY S., DEMIRCI U., Seker M., et al.
Medical oncology (Northwood, London, England)
, cilt.29, ss.3147-54, 2012 (SCI-Expanded, Scopus)
2012
201245. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.
USTAALIOGLU B., BILICI A., KEFELI U., Şeker M., ONCEL M., GEZEN C., et al.
American journal of clinical oncology
, cilt.35, ss.580-6, 2012 (SCI-Expanded, Scopus)
2012
201246. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?
BILICI A., YAPICI H., ERCAN S., Seker M., USTAALIOĞLU B., SALMAN T., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.17, ss.502-7, 2012 (SCI-Expanded, Scopus)
2012
201247. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.
BILICI A., USTAALIOĞLU B., YAVUZER D., Seker M., MAYADAGLI A., GUMUS M.
Digestive diseases and sciences
, cilt.57, ss.1568-75, 2012 (SCI-Expanded, Scopus)
2012
201248. Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls.
Oven U., BILICI A., ERCAN S., ORCUN A., Seker M., OZKAN A., et al.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
, cilt.14, ss.356-61, 2012 (SCI-Expanded, Scopus)
2011
201149. Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.
BILICI A., DANE F., Seker M., USTAALIOĞLU B., ALIUSTAOGLU M., TEMIZ S., et al.
Digestive diseases and sciences
, cilt.56, ss.3226-34, 2011 (SCI-Expanded, Scopus)
2011
201150. Tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?
ŞEKER M., Bilici A., Güler D. Ö., Ustaalioglu B. B., Gozu H., Erkal F. Y., et al.
HEPATO-GASTROENTEROLOGY
, cilt.58, sa.110, ss.1841-1846, 2011 (SCI-Expanded, Scopus)
2011
201151. Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience.
KEFELI U., KAYA S., USTAALIOGLU B., BILICI A., KEFELI A., YILDIRIM M. Ş., et al.
Medical oncology (Northwood, London, England)
, cilt.28, ss.661-6, 2011 (SCI-Expanded, Scopus)
2011
201152. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?
BILICI A., USTAALIOĞLU B., ERCAN S., ORCUN A., Seker M., SALEPCI T., et al.
Cancer chemotherapy and pharmacology
, cilt.68, ss.309-16, 2011 (SCI-Expanded, Scopus)
2011
201153. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast
ŞEKER M., Bilici A., Ustaalioglu B. Ö., Yılmaz B., Öztürk B., Ünal A., et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS
, cilt.284, sa.2, ss.405-409, 2011 (SCI-Expanded, Scopus)
2011
201154. F-18 FDG PET/CT imaging and bronchoscopic image of tracheal recurrence in patient with non-small-cell lung cancer.
Oven U., KEFELI U., BILICI A., USTAALIOGLU R., Seker M., CINARAL F., et al.
Clinical nuclear medicine
, cilt.36, ss.367-9, 2011 (SCI-Expanded, Scopus)
2011
201155. Co-existence of gastrointestinal stromal tumors with other primary neoplasms.
SEVINC A., Seker M., BILICI A., OZDEMIR N., YILDIZ R., USTAALIOGLU B., et al.
Hepato-gastroenterology
, cilt.58, ss.824-30, 2011 (SCI-Expanded, Scopus)
2011
201156. Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: Report of first case and F-18 FDG PET/CT images
Bilici A., Seker M., USTAALIOGLU B. B. O., CANPOLAT N., Salepci T., Gümüş M.
Journal of Korean Medical Science
, cilt.26, sa.4, ss.574-576, 2011 (SCI-Expanded, Scopus)
2011
201157. A retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience
USTAALIOGLU B. B. O., BILICI A., KEFELI U., Seker M., SALEPCI T., UNAL O., et al.
JOURNAL OF BUON
, cilt.16, sa.2, ss.349-352, 2011 (SCI-Expanded, Scopus)
2011
201158. Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients wih breast cancer?
SONMEZ B., Seker M., BILICI A., Yavuz E., Oven U., GUMUS M., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.16, ss.227-32, 2011 (SCI-Expanded, Scopus)
2011
201159. The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma.
USTAALIOĞLU B., Seker M., BILICI A., CANPOLAT N., YILDIRIM E. Ö., KEFELI U., et al.
Medical oncology (Northwood, London, England)
, cilt.28, ss.258-64, 2011 (SCI-Expanded, Scopus)
2011
201160. A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy.
KEFELI U., BILICI A., USTAALIOĞLU B., KEFELI A., YILDIRIM M. Ş., Seker M., et al.
Archives of gynecology and obstetrics
, cilt.283, ss.405-7, 2011 (SCI-Expanded, Scopus)
2011
201161. Primary breast mantle cell lymphoma with atypical relapse patterns.
DANE F., Seker M., Fulden Y., GUNDUZ F., PEKER O., BASARAN G., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.16, ss.181-2, 2011 (SCI-Expanded, Scopus)
2011
201162. The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?
BILICI A., USTAALIOĞLU B., Seker M., KEFELI U., CANPOLAT N., TEKINSOY B., et al.
European journal of nuclear medicine and molecular imaging
, cilt.38, ss.64-73, 2011 (SCI-Expanded, Scopus)
2010
201063. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment.
ALIUSTAOGLU M., BILICI A., USTAALIOĞLU B., KONYA V., GUCUN M., Seker M., et al.
Medical oncology (Northwood, London, England)
, cilt.27, ss.1060-5, 2010 (SCI-Expanded, Scopus)
2010
201064. The association of serum adiponectin levels with histopathological variables in gastric cancer patients
ŞEKER M., Bilici A., Sönmez B., Ustaalioglu B. B., Gümüş M., Gozu H., et al.
MEDICAL ONCOLOGY
, cilt.27, sa.4, ss.1319-1323, 2010 (SCI-Expanded, Scopus)
2010
201065. Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience.
BILICI A., SALEPCI T., DANE F., GUMUS M., USTAALIOĞLU B., Seker M., et al.
Archives of gynecology and obstetrics
, cilt.282, ss.417-25, 2010 (SCI-Expanded, Scopus)
2010
201066. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.
BILICI A., Seker M., USTAALIOĞLU B., YILMAZ B., DOVENTAS A., SALEPCI T., et al.
Medical oncology (Northwood, London, England)
, cilt.27, ss.975-84, 2010 (SCI-Expanded, Scopus)
2010
201067. Case report: soft tissue metastasis from immature teratoma of the testis: second case report and review of the literature.
BILICI A., USTAALIOĞLU B., Seker M., KAYAHAN S.
Clinical orthopaedics and related research
, cilt.468, ss.2541-4, 2010 (SCI-Expanded, Scopus)
2010
201068. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.
BILICI A., Seker M., USTAALIOĞLU B., KEFELI U., YILDIRIM E. Ö., YAVUZER D., et al.
Annals of surgical oncology
, cilt.17, ss.2037-44, 2010 (SCI-Expanded, Scopus)
2010
201069. Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences.
Anatolian M., USTAALIOĞLU B., GUMUS M., UNAL A. S., CAYIR K., SEVER O., et al.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
, cilt.20, ss.698-703, 2010 (SCI-Expanded, Scopus)
2010
201070. Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?
BILICI A., USTAALIOĞLU B., Seker M., CANPOLAT N., TEKINSOY B., SALEPCI T., et al.
European journal of nuclear medicine and molecular imaging
, cilt.37, ss.1259-69, 2010 (SCI-Expanded, Scopus)
2010
201071. Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma.
Seker M., USTAALIOĞLU B., BILICI A., YILDIRIM M. Ş., KEFELI U., BARISIK N., et al.
Leukemia research
, cilt.34, 2010 (SCI-Expanded, Scopus)
2010
201072. Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience.
Oven U., GUMUS M., BILICI A., Seker M., USTAALIOGLU R., KEFELI U., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.15, ss.529-36, 2010 (SCI-Expanded, Scopus)
2010
201073. Preoperative serum leptin levels in patients with breast cancer.
ALIUSTAOGLU M., BILICI A., GUMUS M., COLAK A., BALOGLU G., IRMAK R., et al.
Medical oncology (Northwood, London, England)
, cilt.27, ss.388-91, 2010 (SCI-Expanded, Scopus)
2010
201074. Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience.
USTAALIOĞLU B., GUMUS M., BILICI A., Seker M., DANE F., SALEPCI T., et al.
Medical oncology (Northwood, London, England)
, cilt.27, ss.454-8, 2010 (SCI-Expanded, Scopus)
2010
201075. The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer.
ALIUSTAOGLU M., BILICI A., Seker M., DANE F., GOCUN M., KONYA V., et al.
Hepato-gastroenterology
, cilt.57, ss.640-5, 2010 (SCI-Expanded, Scopus)
2010
201076. Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.
USTAALIOĞLU B., BILICI A., Seker M., CANPOLAT N., OZDEMIR N., SALEPCI T., et al.
Leukemia research
, cilt.34, 2010 (SCI-Expanded, Scopus)
2010
201077. F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome.
BILICI A., USTAALIOĞLU B., Seker M., CANPOLAT N., GUMUS M.
Clinical nuclear medicine
, cilt.35, ss.211-2, 2010 (SCI-Expanded, Scopus)
2010
201078. Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.
Oven U., BILICI A., KEFELI U., Seker M., YILDIRIM E. Ö., SALEPCI T., et al.
Oncology
, cilt.79, ss.105-11, 2010 (SCI-Expanded, Scopus)
2010
201079. Bilateral conjunctival MALT lymphoma mimicking chronic conjunctivitis.
Seker M., OZDEMIR B., BILICI A., USTAALIOĞLU B., SONMEZ B., YILMAZ B., et al.
Onkologie
, cilt.33, ss.317-20, 2010 (SCI-Expanded, Scopus)
2010
201080. The effect of tumor size on overall survival in patients with pT3 gastric cancer: experiences from 3 centers.
BILICI A., UYGUN K., Seker M., USTAALIOĞLU B., ALIUSTAOGLU M., TEMIZ S., et al.
Onkologie
, cilt.33, ss.676-82, 2010 (SCI-Expanded, Scopus)
2010
201081. Lung cancer presenting with extreme leukocytosis.
SALMAN T., Seker M., BILICI A., Basak-Oven U., GUMUS M., YAYLACI M.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.15, ss.193, 2010 (SCI-Expanded, Scopus)
2010
201082. Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?
BILICI A., USTAALIOĞLU B., GUMUS M., Seker M., YILMAZ B., KEFELI U., et al.
Onkologie
, cilt.33, ss.101-5, 2010 (SCI-Expanded, Scopus)
2010
201083. Factors that Affect Patients' Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients.
GUMUS M., USTAALIOGLU B., GARIP M., KIZILTAN E., BILICI A., Seker M., et al.
Breast care (Basel, Switzerland)
, cilt.5, ss.164-168, 2010 (SCI-Expanded, Scopus)
2009
200984. Bilateral primary small lymphocytic lymphoma of the lacrimal sac and review of the literature.
USTAALIOĞLU B., BILICI A., Seker M., GUMUS M., OZDEMIR N., SALMAN T., et al.
Leukemia research
, cilt.33, 2009 (SCI-Expanded, Scopus)
2009
200985. Acute renal failure and multiple extranodal involvement in a patient with diffuse large B cell lymphoma.
Seker M., USTAALIOĞLU B., BILICI A., OZSEKER N., AKSU A., GUMUS M.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.14, ss.726-7, 2009 (SCI-Expanded, Scopus)
2009
200986. Renal cell carcinoma with pulmonary metastasis misdiagnosed as other primary malignant tumor.
Ustaalioglu O., BILICI A., Seker M., SALEPCI T., KESER S., GUMUS M.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.14, ss.727-8, 2009 (SCI-Expanded, Scopus)
2009
200987. Myasthenia gravis and autoimmune Addison disease in a patient with thymoma.
Seker M., GOZU H., Oven U., SONMEZ B., ERKAL F., KOCAK M., et al.
Clinical lung cancer
, cilt.10, ss.367-70, 2009 (SCI-Expanded, Scopus)
2009
200988. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.
Seker M., BILICI A., USTAALIOGLU B., SALMAN T., SONMEZ B., CANPOLAT N., et al.
Leukemia research
, cilt.33, 2009 (SCI-Expanded, Scopus)
2009
200989. Metastatic renal hemangiopericytoma: A rare case report
Bilici A., Ustaalioglu B. B. O., Seker M., Salman T., Igdem A. A., Celik E., et al.
Archive of Oncology
, cilt.17, ss.32-35, 2009 (Scopus)
2009
200990. Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients.
SALEPCI T., YAZICI H., DANE F., TOPUZ E., DALAY N., ONAT H., et al.
Journal of B.U.ON. : official journal of the Balkan Union of Oncology
, cilt.14, ss.495-9, 2009 (SCI-Expanded, Scopus)
2009
200991. Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy.
USTAALIOĞLU B., BILICI A., Seker M., SALMAN T., GUMUS M., BARISIK N., et al.
Onkologie
, cilt.32, ss.424-6, 2009 (SCI-Expanded, Scopus)
2009
200992. Induction Chemotherapy and Chemoradiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer: A Single-Institution Review of Two Different Regimens
KOCAK M., OZKAN A., Mayadagli A., PARLAK C., Bilici A., Seker M., et al.
CLINICAL LUNG CANCER
, cilt.10, sa.2, ss.124-129, 2009 (SCI-Expanded, Scopus)
2009
200993. Gastric pneumatosis intestinalis associated with malignancy: an unusual case report.
BILICI A., KARADAG B., DOVENTAS A., Seker M.
World journal of gastroenterology
, cilt.15, ss.758-60, 2009 (SCI-Expanded, Scopus)
2008
200894. Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer.
KOLDAS M., GUMMUS M., Seker M., SEVAL H., HULYA K., DANE F., et al.
Clinical lung cancer
, cilt.9, ss.112-5, 2008 (SCI-Expanded, Scopus)
2005
200595. Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?
SARGIN H., SARGIN M., GOZU H., ORCUN A., BALOGLU G., OZISIK M., et al.
World journal of gastroenterology
, cilt.11, ss.5874-7, 2005 (SCI-Expanded, Scopus)
2005
200596. The evaluation of left ventricular hypertrophy in hypertensive patients with subclinical hyperthyroidism.
TAMER I., SARGIN M., SARGIN H., Seker M., BABALIK E., TEKCE M., et al.
Endocrine journal
, cilt.52, ss.421-5, 2005 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2023
20231. Non Surgical Management of Aggressive Giant Cell Granuloma of the Mandible with Denosumab: 3 Cases
Kaşarcıoğlu G., Pergel T., AKKOYUN E. F., YÜCESOY T., DEMİRBAŞ A. E., KÜTÜK N., et al.
AÇBİD 16th International Congress, Antalya, Türkiye, 10 Mayıs 2023, (Özet Bildiri)
2021
20212. DIFFERENTIATION OF BRAIN METASTASES FROM BRAIN MRI WITH DEEP CNN
GÜLTEKİN M. A., PEKER A. A., OKTAY A. B., TÜRK H. M., ÇEŞME D. H., Shbair A., et al.
30. YIL ULUSLARARASI KATILIMLI TANISAL ve GİRİŞİMSEL NÖRORADYOLOJİ, BAŞ-BOYUN RADYOLOJİSİ KONGRESİ, İstanbul, Türkiye, 17 - 21 Şubat 2021, (Özet Bildiri)
2019
20193. Renal Hücreli Karsinoma Hastalarında Nefrektomi Esnasında Lenf Nodu DiseksiyonuGerekli mi?
DEMİR T., ARAZ M., KÖSTEK O., SAKİN A., SHBAİR A. T., ALİYEV A., et al.
23. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 17 - 21 Nisan 2019, (Özet Bildiri)
2018
20184. EFFECTS OF PROXEED PLUS IN THE PREVENTION AND TREATMENT OF CISPLATIN NEPHROTOXICITY: AN EXPERIMENTAL RAT STUDY
Dogan E. E., Aydin M. S., Guler E. M., Kocyigit A., Gursu M., Seker M., et al.
55th Congress of the European-Renal-Association (ERA) and European-Dialysis-and-Transplantation-Association (EDTA), Copenhagen, Danimarka, 24 - 27 Mayıs 2018, cilt.33, (Özet Bildiri)
2018
20185. PRIMER TÜMÖR YERLEŞIMININ METASTATIK KOLOREKTAL KANSERLI HASTALARDA PROGNOSTIK ÖNEMI
DEMİR T., ALİYEV A., ÇOBAN E., ŞEKER M., TÜRK H. M., KOÇAK M. Z.
7. TÜRK TIBBI ONKOLOJİ KONGRESİ, Türkiye, 21 - 25 Mart 2018, (Özet Bildiri)
2015
20156. Metacognitive processes in cancer patients
Mutlu H. H., MUTLU H. H., Selek S., MAYADAGLI A., Turk H. M., SEKER M., et al.
European Cancer Congress, Vienna, Avusturya, 01 Ocak 2015, cilt.51, (Özet Bildiri)